Duspatal and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Duspatal (mebeverine hydrochloride), especially for people who are female, 60+ old, also take Celebrex, and have Pain.

The phase IV clinical study analyzes which people have Weakness when taking Duspatal. It is created by eHealthMe based on reports of 507 people who have side effects when taking Duspatal from the FDA, and is updated regularly.

What is Duspatal?

Duspatal has active ingredients of mebeverine hydrochloride. eHealthMe is studying from 540 Duspatal users. Check the latest studies of Duspatal.

What is Weakness?

Weakness is found to be associated with 3,640 drugs and 6,613 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 27, 2026

507 people reported to have side effects when taking Duspatal.
Among them, 49 people (9.66%) have Weakness.

Among these 49 people:

What is the gender of people who have Weakness when taking Duspatal? *

female: 77.55 %
male: 22.45 %

What is the age of people who have Weakness when taking Duspatal? *

What are other drugs people take besides Duspatal? *

What are other side effects people have besides Weakness? *

Dyspnea Exertional: 26 people, 53.06%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 24 people, 48.98%
Pain: 24 people, 48.98%
Hyperhidrosis (abnormally increased sweating): 22 people, 44.90%
Back Pain: 22 people, 44.90%
Fatigue (feeling of tiredness): 21 people, 42.86%
Tremor (trembling or shaking movements in one or more parts of your body): 21 people, 42.86%
Stress And Anxiety: 21 people, 42.86%
Diarrhea: 20 people, 40.82%
Pain In Extremity: 20 people, 40.82%

What are the existing conditions these people have? *

Pain: 31 people, 63.27%
Fibromyalgia (a long-term condition which causes pain all over the body): 17 people, 34.69%
Myosclerosis (hardening of muscle tissue): 16 people, 32.65%
Gastritis - Chronic (long lasting inflammation of stomach): 8 people, 16.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 16.33%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 8 people, 16.33%
Nausea (feeling of having an urge to vomit): 7 people, 14.29%
Lung Neoplasm Malignant (cancer tumour of lung): 7 people, 14.29%
Muscle Aches (muscle pain): 6 people, 12.24%
Back Pain: 5 people, 10.20%

* Approximation only. Some reports may have incomplete information.

Do you take Duspatal and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Duspatal:

Duspatal (540 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Duspatal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,640 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,613 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mebeverine hydrochloride (the active ingredients of Duspatal) and Duspatal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.